If detected early, cancer is much easier to treat. Emerging non-invasive tests can help early diagnosis. As diseases go, cancer is deadly. Its early detection, however, can make a huge difference to ...

The "China Biopsy Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...

It’s estimated that 1 in 100 people have it; however, only 36% with the condition are clinically diagnosed, according to ...

Burning Rock Biotech Limited’s BNR share price has dipped by 12.36%, which has investors questioning if this is right time to ...

Objective: Conventional fine-needle aspiration biopsy (FNAB) for cystic thyroid nodules (CTNs) has a high rate of nondiagnostic and false-negative results. Ultrasound-guided FNAB (UG-FNAB ...

Resmetirom offers a targeted approach to metabolic dysfunction–associated steatohepatitis (MASH) for use alongside lifestyle ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen research ...

"They're basically creating a 'virtual biopsy' that has vast applications ... kidney, breast and thyroid diseases and cancers. PathAI's artificial intelligence tool for diagnosing MASH has become ...

Because of that, several prominent — David Johansen of the New York Dolls, Chris Jasper of The Isley Brothers, DJ Funk and ...

The OPTIMUM study found 4.5% more clinically significant cancers among men who underwent micro-ultrasound–guided biopsies of ...